Not yet recruitingPhase 4NCT07320534

Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Gadjah Mada University
Principal Investigator
Idha Yulandari, M.D. Pediatric
Gadjah Mada University
Intervention
Levofloxacin(drug)
Enrollment
124 enrolled
Eligibility
18 years · All sexes
Timeline
20262026

Study locations (1)

Collaborators

Dr. Sardjito Hospital, Yogyakarta

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07320534 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials